![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 12, 2017 5:30:06 AM
Many exciting contracts in the works and to be announced.
The agreement with Gedeon Richter Mexico S.A.P.I . de C.V. for "Gynofit" is separate from Easton / BMV's other patented and exclusive diagnostic products (VagiSan (VS-Sense) & AmnioSense (AL-Sense) for which Easton is currently in separate late stage negotiations with large multi-national pharmaceutical companies.
In other developments, Easton Pharmaceuticals has entered into and are in late stage negotiations with BMV Medica SA de C.V. to acquire all of BMV and its assets. In addition, Easton is in late stage negotiations for an international medical marijuana initiative and to acquire a profitable and steadily growing Vaporizer company with their own line of manufactured and proprietary e-liquids and accessories, possessing growing international sales. News updates to be made available as they develop.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM